08-05-2025
Aker BioMarine signs agreement for Lysoveta clinical trial
Oslo, 30 April 2025 – Aker BioMarine has signed an agreement with leading clinical research organization KGK Science Inc.,...
30-04-2025
Aker BioMarine Delivers Strong Start to 2025 with Revenue and Earnings Growth
Oslo, 30 April 2025 – Aker BioMarine today reported its financial results for the first quarter of 2025, delivering solid...
31-03-2025
Annual Report 2024: "A transformative year for Aker BioMarine"
2024 was a pivotal year for Aker BioMarine - marked by progress and transformation. We sharpened our focus, accelerated...
27-03-2025
Aker BioMarine Partners with Two Distributors to Introduce New Marine Ingredients in Europe
Aker BioMarine is pleased to announce its exclusive partnerships with two European based distributors to launch new marine...
14-03-2025
Aker BioMarine Shares Future Trends Shaping the Nutraceuticals Industry in 2025 and Beyond
Oslo, Norway – March 2025 – The global nutraceutical market is on the move and shows no sign of slowing down, driven by...
04-12-2024
Aker BioMarine Appoints Jaroslava Juricova-Olsen as CMO for Human Health Ingredients
Oslo, Norway – December 4, 2024 – Aker BioMarine has named Jaroslava Juricova-Olsen as Chief Marketing Officer for its Human...
22-11-2024
New Study: Aker BioMarine's PL+ Innovation Boosts Omega-3 Absorption
Oslo, November 22, 2024 – PL+ EPA/DHA, a new formulation of krill phospholipids with fish oil omega-3, shows more than 10...
19-11-2024
Aker BioMarine Partners with Norwegian Board Association to Advance Sports and Inclusion
(Oslo, Norway, November 19, 2024) — Aker BioMarine joins as a new sponsor and partner of the Norwegian Board Association,...
11-11-2024
Aker BioMarine Secures Key Partnerships at China International Import Expo
Shanghai, China, November 9, 2024 — Aker BioMarine, a global leader in krill-based nutrition, continues to deepen its...